An update on autoimmune inner ear disease: A systematic review of pharmacotherapy☆☆☆
Author links open overlay panelDavidStrumSunnyKimTimothyShimAshkanMonfared
Division of Otolaryngology-Head and Neck Surgery, George Washington University, 2300 M St NW, 4th floor, Washington, DC 20037, United States
Received 26 September 2019, Available online 28 October 2019.
Show less
https://doi.org/10.1016/j.amjoto.2019.102310Get rights and content
Highlights
•
There is insufficient data from randomized-controlled trials to suggest an efficacious treatment for AIED other than systemic corticosteroids
•
There is inconsistent correlation of clinical course of AIED with anti-cochlear antibodies or other immunologic markers
•
AIED may have phenotypes with heterogeneity in immunologic markers, treatment response, and clinical course
Author links open overlay panelDavidStrumSunnyKimTimothyShimAshkanMonfared
Division of Otolaryngology-Head and Neck Surgery, George Washington University, 2300 M St NW, 4th floor, Washington, DC 20037, United States
Received 26 September 2019, Available online 28 October 2019.
Show less
https://doi.org/10.1016/j.amjoto.2019.102310Get rights and content
Highlights
•
There is insufficient data from randomized-controlled trials to suggest an efficacious treatment for AIED other than systemic corticosteroids
•
There is inconsistent correlation of clinical course of AIED with anti-cochlear antibodies or other immunologic markers
•
AIED may have phenotypes with heterogeneity in immunologic markers, treatment response, and clinical course
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου